1. Home
  2. UPBD vs ALVO Comparison

UPBD vs ALVO Comparison

Compare UPBD & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Upbound Group Inc.

UPBD

Upbound Group Inc.

HOLD

Current Price

$19.92

Market Cap

1.1B

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$3.50

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UPBD
ALVO
Founded
1986
2013
Country
United States
Luxembourg
Employees
N/A
1460
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
UPBD
ALVO
Price
$19.92
$3.50
Analyst Decision
Strong Buy
Buy
Analyst Count
4
4
Target Price
$32.25
$8.00
AVG Volume (30 Days)
726.9K
401.1K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
7.89%
N/A
EPS Growth
N/A
N/A
EPS
1.25
N/A
Revenue
$4,695,061,000.00
N/A
Revenue This Year
$5.96
$13.28
Revenue Next Year
$6.47
$18.63
P/E Ratio
$15.80
$18.20
Revenue Growth
8.67
N/A
52 Week Low
$15.82
$3.03
52 Week High
$28.03
$11.85

Technical Indicators

Market Signals
Indicator
UPBD
ALVO
Relative Strength Index (RSI) 59.58 44.66
Support Level $17.05 $3.03
Resistance Level $20.28 $3.93
Average True Range (ATR) 0.75 0.20
MACD 0.25 0.03
Stochastic Oscillator 69.96 26.27

Price Performance

Historical Comparison
UPBD
ALVO

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has four operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions, Mexico segment offers lease-to-own stores in Mexico. The The Brigit segment offers various financial health products and tools to help users improve their financial health. The company derives a majority of its revenue from the Acima segment.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: